Ftse Mib
32.665,21
-2,81%
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
NASDAQ
17.688,88
0,12%
Bitcoin
66.097,93
-0,14%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Eagle Pharmaceuticals Inc (EGRX) Eagle Pharmaceuticals Inc (EGRX) Notizie

Eagle Pharmaceuticals Inc

EGRX
3,85
0,03 (0,79%)
15 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
29/5/202414:20EDGAR2Form 8-K - Current report
22/5/202415:08EDGAR2Form 8-K - Current report
15/5/202415:29EDGAR2Form 8-K - Current report
10/5/202423:27EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
08/3/202422:49EDGAR2Form 8-K - Current report
01/3/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202413:35EDGAR2Form 8-K - Current report
01/3/202402:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202422:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202414:09EDGAR2Form 8-K - Current report
14/2/202423:09EDGAR2Form SC 13D - General statement of acquisition of beneficial..
13/2/202421:53EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202414:50EDGAR2Form 8-K - Current report
09/2/202411:45PRNUSEagle Pharmaceuticals, Inc. Securities Fraud Class Action..
07/2/202415:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/2/202423:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202411:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
26/1/202411:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
19/1/202411:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
18/1/202412:56EDGAR2Form 8-K - Current report
18/1/202412:50GLOBEEagle Pharmaceuticals Provides Update on Bendamustine..
16/1/202413:00EDGAR2Form 8-K - Current report
12/1/202411:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
09/1/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202411:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
23/12/202301:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202323:15EDGAR2Form 8-K/A - Current report: [Amend]
20/12/202322:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
15/12/202323:11EDGAR2Form 8-K - Current report
06/12/202322:26EDGAR2Form 8-K - Current report
06/12/202322:05GLOBEEagle Pharmaceuticals to Present Abstract on Post-hoc..
29/11/202313:39EDGAR2Form 8-K - Current report
29/11/202313:36EDGAR2Form 8-K - Current report
09/11/202323:23EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
09/11/202313:57EDGAR2Form 8-K - Current report
09/11/202313:30GLOBEEagle Delays Third Quarter 2023 Results and Conference Call
08/11/202314:30GLOBEEagle Pharmaceuticals to Host Third Quarter 2023 Financial..
03/11/202321:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202321:53EDGAR2Form 144 - Report of proposed sale of securities
01/11/202322:02EDGAR2Form 144 - Report of proposed sale of securities
31/10/202322:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202314:49EDGAR2Form 8-K - Current report
24/10/202314:40GLOBEEagle Pharmaceuticals Granted Patent for PEMFEXY®
23/10/202313:10EDGAR2Form 8-K - Current report
23/10/202312:50GLOBEEagle Pharmaceuticals Granted Unique J-Code and Pass-Through..
04/10/202323:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202312:50GLOBEEagle Pharmaceuticals Awarded First Prize for Poster to Be..
03/10/202322:48EDGAR2Form 144 - Report of proposed sale of securities
Apertura: 3,83 Min: 3,76 Max: 3,94
Chiusura: 3,82

La tua Cronologia

NASDAQ
EGRX
Eagle Pharmaceuticals
BIT
S29141
Societe Generale Effekten
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network